Sign in Subscribe
BioMed

🧬 BioMed Pulse · 2026-08-15 02:02 UTC

BIOMED PULSE

August 15, 2026 | Your daily briefing on longevity, viruses, and new cures

⚡ TL;DR

The Bundibugyo virus Ebola outbreak in DRC and Uganda has now reached 2,124 confirmed cases and 828 deaths as of July 15, 2026 — the most severe active outbreak on the planet right now. [1]

Mood: Cautiously alarmed on multiple fronts; the Ebola surge dominates while foodborne and longevity research signals are mixed but active.

🦠 OUTBREAKS & VIRUSES

EBOLA (BUNDIBUGYO VIRUS) — DRC AND UGANDA

  • As of August 1, 2026, the Bundibugyo virus disease (BVD) outbreak in DRC has intensified beyond Ituri Province's Mongbwalu health zone over the past two months, with continued geographic spread and cross-border transmission to Uganda. [2]
  • The last WHO Disease Outbreak News update, covering data through July 15, recorded 2,124 confirmed cases and 828 deaths in DRC alone, representing a case fatality rate near 39% among confirmed cases. [1]
  • CDC had activated enhanced Ebola airport screening at Washington-Dulles International Airport (May 21) and Atlanta (May 23), with ongoing daily briefings through late June 2026. [3] [4]
  • WHO declared the outbreak using Bundibugyo ebolavirus, a distinct species from the more common Zaire strain, first identified in Uganda in 2007; this strain has historically shown case fatality rates of 25-50%. [5] [6]

ANDES HANTAVIRUS — M/V HONDIUS CRUISE SHIP, MULTI-COUNTRY

  • WHO's fifth Disease Outbreak News posting (July 2, 2026) confirmed the M/V Hondius-linked Andes hantavirus (ANDV) outbreak remains under investigation across multiple countries. [7]
  • The outbreak was first notified to WHO on May 2, 2026; the ship carried 147 passengers and crew, and early reports identified at least two laboratory-confirmed ANDV cases plus additional suspected cases. [8]
  • CDC issued multiple briefing transcripts through June 24, 2026, noting the risk to the American public remains extremely low. [9] [10]

CYCLOSPORA — TACO BELL / ICEBERG LETTUCE, MULTI-STATE USA

  • CDC identified shredded iceberg lettuce served at Taco Bell locations as the source of a Cyclospora outbreak affecting five states, with 1,644 people sick as of July 17, 2026.
  • The outbreak subsequently expanded to four additional states, per a July 24, 2026 CDC update.
  • Cyclospora cayetanensis is a microscopic parasite spread via contaminated food or water; illness typically causes prolonged watery diarrhea for weeks if untreated.

SALMONELLA — JALAPEÑOS, MULTI-STATE USA

  • CDC posted a food safety alert on August 5, 2026 warning of a multistate Salmonella outbreak linked to jalapeños.

NIPAH VIRUS — KERALA, INDIA

  • WHO confirmed one laboratory-confirmed Nipah virus (NiV) infection in Kozhikode district, Kerala, India; the adult male developed symptoms May 30, 2026 and was hospitalized June 10, 2026 with neurological presentation.
  • NiV in Kerala has caused repeated small outbreaks since 2018; the case fatality rate in past Kerala clusters exceeded 50%, making each case a high-priority surveillance event.

YELLOW FEVER — GLOBAL

  • WHO's June 24, 2026 report documented 79 human infections across six countries from January 1 to May 26, 2026, following elevated 2025 transmission in the Americas that carried into 2026.

MPOX — RECOMBINANT STRAIN, GLOBAL

  • WHO reported in February 2026 two cases of a novel recombinant MPXV strain combining genomic elements of both clade Ib and clade IIb, the first documented hybrid of these two lineages.
  • Recombination is a known natural process when two viral strains co-infect the same individual; WHO flagged this as a signal requiring enhanced viral characterization.

MEASLES — BANGLADESH

  • Bangladesh notified WHO on April 4, 2026 of a nationwide measles surge affecting 58 of 64 districts across all eight divisions, with 19,161 suspected cases and 2,897 laboratory-confirmed cases.

WEST NILE VIRUS — USA

  • CDC flagged an early and record-setting West Nile virus season heading into the July 4, 2026 holiday weekend, urging mosquito bite prevention.

🧬 LONGEVITY & AGING

SENESCENCE IN OSTEOARTHRITIS — DUAL-MODAL INTERVENTION

  • A new study in Bioactive Materials (An X et al., July 2026) shows that combining antioxidant therapy with epigenetic modification can break the self-perpetuating senescence cycle in osteoarthritis cartilage cells, potentially halting joint degeneration at its biological root.
  • Cellular senescence in joints drives a feedback loop: senescent cells release inflammatory signals that push neighboring cells into senescence, worsening cartilage breakdown over time.

PUNICALAGIN AND BONE AGING — NRF2/HO-1 PATHWAY

  • Research published in Regenerative Therapy (Wang Y et al., July 25, 2026) found that punicalagin — a polyphenol from pomegranates — alleviates senile osteoporosis by suppressing senescence in bone mesenchymal stem cells via the NRF2/HO-1 antioxidant pathway.
  • By reducing oxidative stress in stem cells, punicalagin appears to preserve their ability to regenerate bone tissue, a key mechanism underlying age-related bone loss.

METFORMIN FOR PHYSICAL FUNCTION IN OLDER OBESE ADULTS — DEMFOS TRIAL

  • The DEMFOS randomized controlled trial (Lancet Healthy Longevity, Nava MLD et al.) tested metformin added to lifestyle intervention in older adults with obesity, finding the combination affected physical function outcomes.
  • An accompanying editorial by Witham MD and McDonald C warns against inflated expectations for adjunctive metformin in managing obesity and frailty in older people.

STATIN DEPRESCRIBING IN ADULTS AGED 75 AND OLDER — SAGA/SITE TRIAL

  • The multicenter, open-label, pragmatic SAGA/SITE trial published in Lancet Healthy Longevity (Bonnet F et al.) evaluated whether stopping statins for primary cardiovascular prevention in adults 75 and older is non-inferior to continuing them.
  • An editorial commentary (Arya Nezhad S et al.) argues the findings should shift clinical conversations around statin deprescribing in older adults from "if" to "how" and "when."

P16-INK4A ANTIBODY VALIDATION — PANCREATIC SENESCENCE MARKER

  • Pipella J and Thompson PJ (Islets journal, July 21, 2026) highlight a critical methodological issue: widely used antibodies for detecting p16-INK4A, a key cellular senescence biomarker, show variable reliability in pancreatic tissue via immunohistochemistry, raising concerns about the reproducibility of senescence studies in this organ.

POSITIVE LIFE ORIENTATION AND BLOOD PRESSURE IN OLDER ADULTS

  • A study using two Finnish generational cohorts born 20 years apart (Lääti A et al., Blood Press, August 7, 2026) found that positive life orientation is associated with lower blood pressure in older adults, suggesting psychological well-being has measurable cardiovascular relevance across generations.

EPIGENETIC AGE AND DIET IN DOGS — PILOT STUDY

  • A pilot study in Veterinary Record Open (Chen A et al., August 5, 2026) found that feeding dogs a minimally processed, human-grade diet altered their epigenetic aging clock, providing early animal-model evidence that diet quality can modulate biological aging rate.

TELOMERE REPAIR AND SENESCENCE IN CANCER CELLS

  • Salmina K et al. (Nucleus journal, July 23, 2026) examined how doxorubicin-treated cancer cells repair and misrepair telomeric DNA through dynamic interactions with PML nuclear bodies and lamin B1, illuminating a mechanism by which chemotherapy-induced DNA damage at telomeres can trigger or sustain senescence.

KIDNEY FUNCTION MARKERS IN OLDER CHINESE ADULTS

  • A completed observational cohort study (ClinicalTrials NCT07765134) assessed a comprehensive panel of clinical and molecular kidney function markers — covering glomerular filtration, tubular transport, and endocrine function — in two cohorts of Chinese adults aged 60 and older, aiming to enable earlier warning of age-related kidney decline.

💊 NEW CURES & APPROVALS

METFORMIN-COMBINATION SUPPLEMENTAL APPROVALS — MULTIPLE SPONSORS

  • openFDA records show supplemental approvals (SUPPL AP) for multiple metformin-containing combination products: AstraZeneca's XIGDUO XR (dapagliflozin/metformin), Boehringer Ingelheim's SYNJARDY XR (empagliflozin/metformin), and Janssen's INVOKAMET and INVOKAMET XR (canagliflozin/metformin) — all type 2 diabetes combination agents.
  • Zydus Lifesciences received supplemental approvals for both ZITUVIMET (sitagliptin/metformin immediate-release) and ZITUVIMET XR (extended-release), and Takeda's ACTOPLUS MET (pioglitazone/metformin) also received a supplemental action.
  • Several generic metformin hydrochloride products from manufacturers including Yichang Humanwell, Nostrum Pharma, Glenmark, and Prinston Inc also received supplemental approvals.

NOTE: openFDA entries lack precise dates for these actions; they reflect the most recent supplemental approval activity in the system and are informational only, not indicative of new molecular entities.

🧪 CLINICAL TRIALS

MK-2214 FOR EARLY ALZHEIMER'S DISEASE — PHASE STUDY (NCT07033494)

  • Merck's MK-2214-004 study is evaluating whether MK-2214 can slow specific brain changes in early Alzheimer's disease, with updated trial records as of August 14, 2026; the compound targets AD-related pathology mechanisms.

PEMBROLIZUMAB FOR NEUROLOGICAL LONG COVID — PHASE I (NCT07388550)

  • A Phase I open-label safety trial (PD1-PASC I) is testing pembrolizumab — a PD-1 checkpoint inhibitor — for neurological post-acute sequelae of SARS-CoV-2, targeting persistent symptoms like headache, cognitive difficulty, and sensory loss; updated August 14, 2026.
  • The rationale is that persistent immune dysregulation or viral remnants in neurological Long Covid may respond to immune checkpoint modulation.

ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE 4 — ADNI4 (NCT05617014)

  • ADNI4, a longitudinal natural history study building on ADNI1-3, continues enrolling participants to validate biomarkers, improve Alzheimer's clinical trial design, and characterize the full disease spectrum; record updated August 14, 2026.

EXERCISE DURING CHEMOTHERAPY IN OLDER BREAST CANCER PATIENTS (NCT05025059)

  • This feasibility trial evaluates structured physical activity programs during chemotherapy in older women with Stage I-III breast cancer, investigating whether exercise can reduce chemotherapy toxicity burden in an aging oncology population.

TSLPR-CART CELLS FOR REFRACTORY B-CELL ALL (NCT07572136)

  • A trial of anti-CRLF2-R/TSLPR chimeric antigen receptor T cells is recruiting participants with recurrent or refractory CRLF2-R/TSLPR-overexpressing B-cell acute lymphoblastic leukemia, a genetically hard-to-treat subtype; updated August 14, 2026.

KIDNEY FUNCTION COHORT IN OLDER ADULTS — COMPLETED (NCT07765134)

  • This completed observational study enrolled Chinese adults aged 60 and older to assess comprehensive kidney function biomarkers for early warning of renal aging; results are available.

SAT-3247 FOR DUCHENNE MUSCULAR DYSTROPHY — PHASE 2a (NCT07287189)

  • A randomized, double-blind, placebo-controlled Phase 2a trial is evaluating SAT-3247 at two doses in ambulatory DMD patients aged 7 to under 10, over 12 weeks, assessing dose, safety, tolerability, and preliminary efficacy.

📢 PUBLIC HEALTH

CDC SALMONELLA ALERT — JALAPEÑOS (AUGUST 5, 2026)

  • CDC issued a multistate Salmonella food safety alert linked to jalapeños; consumers should check product recalls and avoid implicated items.

CYCLOSPORA — AVOID TACO BELL SHREDDED LETTUCE IN AFFECTED STATES

  • With 1,644 confirmed sick across at least nine states as of late July 2026, the Taco Bell/iceberg lettuce Cyclospora outbreak remains one of the largest active U.S. foodborne events; treatment is trimethoprim-sulfamethoxazole.

WEST NILE VIRUS — ELEVATED EARLY SEASON, USA

  • CDC data showed ER visits for tick bites were also higher than usual this spring (April 23, 2026), compounding a multi-vector insect-borne disease threat this summer.

EBOLA AIRPORT SCREENING REMAINS IN PLACE

  • Enhanced Bundibugyo virus screening continues at Dulles and Atlanta Hartsfield-Jackson airports for travelers arriving from DRC and Uganda; travelers from those regions should self-monitor for fever, hemorrhagic symptoms, and myalgia for 21 days. [3] [4]

NEW WORLD SCREWWORM — CDC EMERGENCY OPERATIONS CENTER ACTIVATED

  • CDC activated its Emergency Operations Center for a New World Screwworm (Cochliomyia hominivorax) response on June 12, 2026; this flesh-eating fly larva can infest open wounds in both animals and humans.

INFANT BOTULISM — NARA ORGANICS FORMULA RECALL STILL ACTIVE

  • CDC's June 13, 2026 outbreak update urged parents to immediately stop using all Nara Organics Whole Milk Organic Infant Formula linked to an infant botulism cluster.

BIOSURVEILLANCE MILESTONE

  • CDC's Traveler-Based Genomic Surveillance program surpassed one million voluntary air travel participants as of January 30, 2026, enhancing the agency's ability to detect novel pathogen introductions at U.S. ports of entry.

This briefing is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider for personal health decisions.

📎 Sources

  1. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  2. Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
  3. Enhanced Ebola Airport Screening Begins at Washington-Dulles I… — CDC Newsroom
  4. Enhanced Ebola Airport Screening Expands to Atlanta — CDC Newsroom
  5. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  6. Ebola disease caused by Bundibugyo virus – Democratic Republic… — WHO Disease Outbreak News
  7. Hantavirus outbreak linked to cruise ship travel, Multi-locations — WHO Disease Outbreak News
  8. Hantavirus cluster linked to cruise ship travel, Multi-country — WHO Disease Outbreak News
  9. Transcript - Update on CDC's Hantavirus Response - 6/24/26 — CDC Newsroom
  10. CDC Provides Update on Hantavirus Outbreak Linked to M/V Hondi… — CDC Newsroom

Curated from official sources — WHO/CDC/ECDC/openFDA/ClinicalTrials.gov/Europe PMC. Informational only — not medical advice.
Serial 20260815-02-v56 · 2026-08-15 02:02 UTC · pulse.uzylab.com

Read next